2003
DOI: 10.1002/ange.200351942
|View full text |Cite
|
Sign up to set email alerts
|

“Cascade‐Release Dendrimers” Liberate All End Groups upon a Single Triggering Event in the Dendritic Core

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(38 citation statements)
references
References 28 publications
0
38
0
Order By: Relevance
“…Hypothetical mechanism for mitosis inhibition by glycopeptide conjugates of colchicine. The glycopeptide dendrimer drug conjugate is taken into the cell (1), and is then degraded by intracellular proteases to release colchicine (2). Colchicine binds to tubulin and inhibits its polymerization (3), thereby blocking mitosis.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Hypothetical mechanism for mitosis inhibition by glycopeptide conjugates of colchicine. The glycopeptide dendrimer drug conjugate is taken into the cell (1), and is then degraded by intracellular proteases to release colchicine (2). Colchicine binds to tubulin and inhibits its polymerization (3), thereby blocking mitosis.…”
Section: Resultsmentioning
confidence: 99%
“…The solvent was then removed in vacuo and the residue was purified by flash chromatography on silica gel (AcOEt/acetone, 4:1, R f = 0.28) to give N-Boc-colchicine (0.187 mg, 0.38 = 179.9, 164.7, 154.2, 154.1, 151.8, 151.2, 142.3, 137.5, 136.3, 134.7, 133.3, 126.7, 113.7, 107.8, 85.5, 62.2, 62.1, 58.5, 57.0, 56.7, 33.3, 30.8, 30.3, 28.5, 2, 164.6, 154.9, 154.1, 151.8, 142.2, 136.6, 135.6, 134.9, 131.8, 126.3, 112.7, 107.8, 80.5, 62.1, 61.2, 61.0, 56.9, 56.7, 53.7, 38.3, 30.6, 28.9 = 179.6, 164.7, 154.7, 151.6, 147.4, 142.2, 137.3, 137.2, 134.4, 132.0, 125.1, 114.4, 108.3, 61.9, 61.9, 57.2, 56.7, 54.5, 36.4, 30. 166.4, 164.8, 154.3, 151.9, 150.8, 142.5, 136.8, 136.1, 134.6, 131.3, 126.2, 113.2, 108.1, 62.1, 62.1, 57.1, 56.8, 53.3, 43.1, 37.5, 30.4 164.7, 160.1, 154.1, 151.9, 151.6, 150.2, 142.4, 137.8, 136.8, 135.8, 134.8, 131.6, 126.4, 121.9, 121.1, 112.9, 108.0, 62.2, 62.1, 57.0, 56.8, 53.0, 37.6, 36.4, 35.8, 30.6 O- (2,3,4,-N-oxyphthalimide (7): A 30 % solution of HBr in AcOH (8.2 mL, 0.142 mol, 11 equiv) was added dropwise to a solution of a-d-glucose pentaacetate 6 (5.06 g, 0.013 mol) in CH 2 Cl 2 (30 mL) at 0 8C. The resulting mixture was stirred at 0 8C for 30 min and then at room temperature for 3 h. After the addition of further CH 2 Cl 2 , the solution was washed with cold water and with a cold solution of NaHCO 3 .…”
Section: N-[(tert-butoxy)carbonyl]colchicinementioning
confidence: 99%
See 1 more Smart Citation
“…However, it should be noted that geometric disassembly of dendritic structures is a known concept in organic chemistry, with interesting implications in areas such as drug delivery. [16] …”
Section: Multimetallic Dendrimersmentioning
confidence: 99%
“…[8,9] Since, for steric reasons, a larger number of molecules can be attached to the dendrimer surface than could possibly be physically trapped within the dendritic branches, the release of bioactive compounds by covalentbond cleavage from the dendrimer surface is particularly interesting for high-generation dendrimers. Redox reactions, [10][11][12] photofragmentations, [13][14][15] hydrolyses [16][17][18][19] and the action of enzymes or catalytic antibodies [20][21][22][23] were identified as the most common triggers for covalent-bond cleavage at the dendrimer surface. Besides drug delivery, this concept was also successfully used to control the release of fragrances.…”
Section: Introductionmentioning
confidence: 99%